Scar Revision - (0328) — MM 0328 | CIGNA Coverage Update

Cigna modified MM 0328 for scar revision, effective September 26, 2025. Here's what billing teams need to know before submitting claims.

Cigna Healthcare updated its scar revision coverage policy under MM 0328 — the policy governing methods used to revise scar tissue. This update affects 26 CPT codes and 16 HCPCS codes, including fractional ablative laser procedures (0479T, 0480T), autologous grafting (15769), filler injections (11950–11954), dermabrasion (15780–15787), chemical peels (15788–15793), and several injectable agents. The line between medically necessary and cosmetic is the central issue here — and where most claim denials will come from.

Quick-Reference Table

Cigna Scar Revision Coverage Criteria and Medical Necessity Requirements 2025

The Cigna scar revision coverage policy under MM 0328 draws a hard line: functional impairment drives coverage, cosmetic improvement does not. If your documentation can't show that the scar limits function — not just appearance — expect a denial.

The codes that Cigna considers medically necessary are CPT 0479T and 0480T (fractional ablative laser fenestration of burn and traumatic scars for functional improvement) and CPT 15769 (grafting of autologous soft tissue harvested by direct excision). HCPCS J9190 (fluorouracil injection, 500 mg) also falls in the covered column when criteria are met. These four are the narrow window of coverage in an otherwise restrictive policy.

For 0479T and 0480T specifically, the clinical basis is explicit: these codes describe fractional ablative laser treatment for burn and traumatic scars when the goal is functional improvement. "Functional improvement" isn't decoration here — it's the coverage trigger. Your documentation needs to name the functional limitation, not just describe the scar's appearance.

Prior authorization requirements aren't spelled out explicitly in the published MM 0328 criteria, but given how many codes in this policy default to cosmetic/not medically necessary, you should treat prior auth as a practical necessity for any covered service. If your Cigna contract requires PA for surgical or laser procedures, this policy doesn't override that. Check your contract terms and confirm with Cigna's PA line before scheduling.

Cigna Scar Revision Exclusions and Non-Covered Indications

This is where MM 0328 does most of its work — and where your billing team faces the most exposure.

Cigna considers a wide range of scar revision methods cosmetic and not medically necessary when used to improve the appearance of a scar. That language — "when used to repair or improve the appearance of a scar" — appears across the bulk of codes in this policy. It covers nearly every technique outside the narrow medically necessary group.

Filler injections under CPT 11950, 11951, 11952, and 11954 (subcutaneous injection of filling material including collagen, from 1 cc up to over 10 cc) are all considered not medically necessary or cosmetic. Fat grafting codes 15771, 15772, 15773, and 15774 — covering autologous fat harvested by liposuction to trunk, extremities, and face — carry the same designation.

Dermabrasion codes 15780 through 15783 and abrasion codes 15786 and 15787 are cosmetic under this policy. So are chemical peels (15788, 15789, 15792, 15793) and all suction-assisted lipectomy codes (15876, 15877, 15878, 15879). The unlisted skin procedure code 17999 is also flagged as not medically necessary or cosmetic in this context.

On the HCPCS side, Cigna considers botulinum toxin injections (J0585, J0586), biologic agents including etanercept (J1438) and interferon variants (J1826, J1830, J9212, J9213, J9214, J9215, J9216, Q3027, Q3028, S0145, S0148), and bleomycin (J9040) as not medically necessary for scar revision. That's a long list of agents that some practices may be billing with the expectation of coverage — and won't get it.

The real issue here is that several of these agents — interferon, bleomycin, fluorouracil — have clinical evidence supporting use in keloid and hypertrophic scar management. Cigna covers fluorouracil (J9190) but draws the line at most other injectables. If you're using bleomycin or interferon in your scar treatment protocols and billing Cigna, review those claims now. The effective date of September 26, 2025 is your line in the sand.

Coverage Indications at a Glance

Cigna Scar Revision Billing Guidelines and Action Items 2025

1. Audit your active scar revision claims before September 26, 2025.
Pull every open or pending claim with codes in the MM 0328 range. Flag anything using 11950–11954, 15771–15774, 15780–15787, 15788–15793, or 15876–15879. Those all land on the cosmetic/not covered side of this policy.

2. Update your charge capture templates to reflect the covered vs. not covered split.
Mark 0479T, 0480T, 15769, and J9190 as conditionally covered — requiring functional impairment documentation. Flag all other codes in this policy as requiring a cosmetic/self-pay workflow for Cigna patients.

3. Build a documentation standard for functional impairment before billing 0479T or 0480T.
"Functional improvement" is the coverage trigger for the laser codes. Your notes need to state explicitly what function is limited — range of motion, contracture, impaired wound healing — not just describe the scar's appearance or the patient's cosmetic concern.

4. Review all HCPCS injectable billing for Cigna scar revision claims.
If your practice uses bleomycin (J9040), interferon variants, or botulinum toxin (J0585, J0586) for keloid or hypertrophic scar treatment and bills Cigna, those claims will not get reimbursement under MM 0328. Redirect those patients to a self-pay discussion before treatment if Cigna is the payer.

5. Separate fluorouracil (J9190) from other injectables in your billing workflow.
J9190 is the one injectable agent Cigna covers under this policy. Make sure your team doesn't batch it with the not-covered injectables in your coding process. It needs its own documentation path showing the applicable medical necessity criteria are met.

6. Confirm prior authorization protocols for covered codes with Cigna.
Before scheduling fractional ablative laser or autologous grafting for Cigna patients after September 26, 2025, confirm whether your contract requires PA. The policy doesn't spell this out, but your contract may. A single unverified PA miss on a laser procedure creates a clean claim denial that's hard to overturn.

7. Talk to your compliance officer if you bill a high volume of dermabrasion or chemical peel codes.
If your practice has historically billed 15780–15793 with functional justifications and gotten coverage, this policy change is a signal to revisit that. MM 0328 now makes the cosmetic designation explicit. Your compliance officer should review whether your documentation strategy still holds under the updated policy language.

CPT, HCPCS, and ICD-10 Codes for Scar Revision Under MM 0328

Covered CPT Codes (When Medical Necessity Criteria Are Met)

Covered HCPCS Codes (When Medical Necessity Criteria Are Met)

Not Covered / Cosmetic CPT Codes

Not Medically Necessary HCPCS Codes

No ICD-10-CM codes are specified in the MM 0328 policy data.